Treatment of hyperprolactinaemia with metergoliie for periods up to 5 years: Clinical and biological tolerability

L. Falsetti, A. M. Voltolini, M. Schimberni, A. E. Pontiroli

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Forty patients with hyperprolactinaemia were treated with metergoline (8 to 12 mg/day) for periods up to 5 years. Analysis of the results of clinical and biological tolerability showed that treatment was generally well tolerated and although 28 patients complained of drug-related side-effects of various kinds, principally nausea, these were usually mild, present at the beginning of treatment and disappeared spontaneously in spite of continued metergoline administration over a prolonged period. No patient stopped treatment because of side-effects. Laboratory parameters also stayed within normal levels and there was no evidence of any alterations in the ECG. It is concluded, therefore, that metergoline is a well-tolerated as well as an effective ergolinic compound for use in those patients in whom prolonged treatment with a prolactin-lowering drug is considered necessaiy.

Original languageEnglish
Pages (from-to)327-332
Number of pages6
JournalCurrent Medical Research and Opinion
Volume8
Issue number5
DOIs
Publication statusPublished - 1983

Fingerprint

Hyperprolactinemia
Metergoline
Therapeutics
Drug-Related Side Effects and Adverse Reactions
Prolactin
Nausea
Electrocardiography
Pharmaceutical Preparations

Keywords

  • Hyperprolactinaemia
  • Metergoline

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Treatment of hyperprolactinaemia with metergoliie for periods up to 5 years : Clinical and biological tolerability. / Falsetti, L.; Voltolini, A. M.; Schimberni, M.; Pontiroli, A. E.

In: Current Medical Research and Opinion, Vol. 8, No. 5, 1983, p. 327-332.

Research output: Contribution to journalArticle

@article{37c7a3cffd134bce9e45c54473909849,
title = "Treatment of hyperprolactinaemia with metergoliie for periods up to 5 years: Clinical and biological tolerability",
abstract = "Forty patients with hyperprolactinaemia were treated with metergoline (8 to 12 mg/day) for periods up to 5 years. Analysis of the results of clinical and biological tolerability showed that treatment was generally well tolerated and although 28 patients complained of drug-related side-effects of various kinds, principally nausea, these were usually mild, present at the beginning of treatment and disappeared spontaneously in spite of continued metergoline administration over a prolonged period. No patient stopped treatment because of side-effects. Laboratory parameters also stayed within normal levels and there was no evidence of any alterations in the ECG. It is concluded, therefore, that metergoline is a well-tolerated as well as an effective ergolinic compound for use in those patients in whom prolonged treatment with a prolactin-lowering drug is considered necessaiy.",
keywords = "Hyperprolactinaemia, Metergoline",
author = "L. Falsetti and Voltolini, {A. M.} and M. Schimberni and Pontiroli, {A. E.}",
year = "1983",
doi = "10.1185/03007998309112392",
language = "English",
volume = "8",
pages = "327--332",
journal = "Current Medical Research and Opinion",
issn = "0300-7995",
publisher = "Informa Healthcare",
number = "5",

}

TY - JOUR

T1 - Treatment of hyperprolactinaemia with metergoliie for periods up to 5 years

T2 - Clinical and biological tolerability

AU - Falsetti, L.

AU - Voltolini, A. M.

AU - Schimberni, M.

AU - Pontiroli, A. E.

PY - 1983

Y1 - 1983

N2 - Forty patients with hyperprolactinaemia were treated with metergoline (8 to 12 mg/day) for periods up to 5 years. Analysis of the results of clinical and biological tolerability showed that treatment was generally well tolerated and although 28 patients complained of drug-related side-effects of various kinds, principally nausea, these were usually mild, present at the beginning of treatment and disappeared spontaneously in spite of continued metergoline administration over a prolonged period. No patient stopped treatment because of side-effects. Laboratory parameters also stayed within normal levels and there was no evidence of any alterations in the ECG. It is concluded, therefore, that metergoline is a well-tolerated as well as an effective ergolinic compound for use in those patients in whom prolonged treatment with a prolactin-lowering drug is considered necessaiy.

AB - Forty patients with hyperprolactinaemia were treated with metergoline (8 to 12 mg/day) for periods up to 5 years. Analysis of the results of clinical and biological tolerability showed that treatment was generally well tolerated and although 28 patients complained of drug-related side-effects of various kinds, principally nausea, these were usually mild, present at the beginning of treatment and disappeared spontaneously in spite of continued metergoline administration over a prolonged period. No patient stopped treatment because of side-effects. Laboratory parameters also stayed within normal levels and there was no evidence of any alterations in the ECG. It is concluded, therefore, that metergoline is a well-tolerated as well as an effective ergolinic compound for use in those patients in whom prolonged treatment with a prolactin-lowering drug is considered necessaiy.

KW - Hyperprolactinaemia

KW - Metergoline

UR - http://www.scopus.com/inward/record.url?scp=0020646915&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0020646915&partnerID=8YFLogxK

U2 - 10.1185/03007998309112392

DO - 10.1185/03007998309112392

M3 - Article

C2 - 6839798

AN - SCOPUS:0020646915

VL - 8

SP - 327

EP - 332

JO - Current Medical Research and Opinion

JF - Current Medical Research and Opinion

SN - 0300-7995

IS - 5

ER -